The cheapest tirzepatide in 2026 starts at $125 a month.
That's compounded tirzepatide from a 503A telehealth pharmacy. The cheapest FDA-approved option is a Zepbound vial through LillyDirect at $299 per month. Brand-name Mounjaro and Zepbound still retail between $1,000 and $1,400 a month without insurance, but almost nobody actually pays that anymore. Here's exactly where the floor sits, what you give up at each price tier, and the red flags that turn a cheap headline into an expensive mistake.
🔑 Key Takeaways
- Compounded tirzepatide from a 503A pharmacy via telehealth runs $125 to $399 per month, with Trimi and GobyMeds anchoring the floor.
- LillyDirect Self Pay sells Zepbound vials at $299 (2.5 mg), $399 (5 mg), and $449 (7.5 to 15 mg), the cheapest FDA-approved cash price for tirzepatide.
- The Mounjaro and Zepbound savings cards drop monthly cost to $25 if you have commercial insurance and a qualifying diagnosis (T2D for Mounjaro, obesity for Zepbound).
- FDA enforcement on compounded tirzepatide tightened on March 5, 2025; reputable pharmacies now require a "personalized" formulation justification, often a B12 additive.
- Hidden fees, dose-tier price jumps at 7.5 mg, and 6 to 12 month prepayment lock-ins can add 30% to 60% to a quoted "starting at" price.
Cheapest Tirzepatide Options in 2026, Ranked
Pricing reset twice in the last year: the FDA ended the tirzepatide shortage in late 2024, and Eli Lilly launched LillyDirect single-dose vial pricing that crushed the brand cash market. Here's what the floor looks like now.
| Option | Form | Monthly cost | FDA-approved | Best for |
|---|---|---|---|---|
| Compounded tirzepatide (Trimi) | Injection | $125 | No (503A) | Absolute cheapest |
| Compounded tirzepatide (Henry Meds, Eden, Peak) | Injection | $229 to $349 | No (503A) | Established providers |
| Compounded tirzepatide oral/troche | Tablet/lozenge | $279 to $399 | No (503A) | Needle-averse |
| Zepbound vials (LillyDirect) | Vial + syringe | $299 to $449 | Yes | Cheapest FDA-approved |
| Mounjaro / Zepbound savings card | Pen injector | $25 | Yes | Commercial insurance |
| Brand Mounjaro / Zepbound retail | Pen injector | $1,000 to $1,400 | Yes | Last resort cash |
1. Compounded Tirzepatide: $125 to $399 per Month
Compounded tirzepatide is what every cheap-tirzepatide article points to first. The legal landscape narrowed when the FDA ended the shortage in late 2024 and finished its enforcement grace period on March 5, 2025. Compounded tirzepatide is still legal under 503A rules, but the formulation must be "personalized" for the patient, usually with a small added ingredient like B12 or a specific dosing strength not commercially available.
The cheapest verified providers as of May 2026:
Lowest-cost compounded tirzepatide telehealth providers
- Trimi: $125 per month, all-in, with B12 personalization
- GobyMeds: $119 to $179 per month (limited dose tiers)
- ReflexMD: starting $92 per month at intro dose
- Peak Wellness: $229 first month / $349 ongoing, or $1,396 for 6 months ($232 per month)
- Eden Health: $299 first month / $349 ongoing
- Henry Meds: $299 to $349 per month, $234 if prepaid annually
- MyStart Health: $299 per month all-inclusive
- Hims/Hers: $199 to $299 per month
- Mochi Health: $208 per month all-in
- Shed (ShedRx): $299 to $399 (jumps at 7.5 mg)
- Willow: $399 per month (32 states)
Honest tradeoff: compounded tirzepatide is not FDA-approved as a finished injectable. The active molecule is identical to what's in Mounjaro and Zepbound. The compounding pharmacy is state-licensed and federally regulated. What you give up is the FDA's review of the finished formulation and the manufacturer's quality-control chain. For most healthy adults that's an acceptable trade for an 80% to 90% price reduction. For pregnant women, anyone with a thyroid cancer history, or anyone with severe pancreatitis risk, it isn't.
2. LillyDirect Zepbound Vials: $299, $399, $449
This is the price that broke the brand cash-pay market. Eli Lilly began selling single-dose Zepbound vials directly to consumers in 2024, at prices that beat almost every compounding pharmacy's "all-inclusive" rate once you add membership fees and labs.
| Zepbound vial dose | LillyDirect cash price | Annual cost |
|---|---|---|
| 2.5 mg (starting dose) | $299 per month | $3,588 |
| 5 mg | $399 per month | $4,788 |
| 7.5 mg | $449 per month | $5,388 |
| 10 mg | $449 per month | $5,388 |
| 12.5 mg | $449 per month | $5,388 |
| 15 mg | $449 per month | $5,388 |
You get a vial and draw the dose with a separate syringe. That's the only friction. The active drug is identical to the auto-injector pen. To stay in the program you have to refill within 45 days; gaps reset the pricing tier.
For anyone who wants FDA-approved tirzepatide and is comfortable with a vial-and-syringe workflow, this is the cheapest legal path that carries the manufacturer label.
3. Mounjaro and Zepbound Savings Cards: $25 per Month
If you have commercial insurance (employer plan or marketplace, not Medicare or Medicaid), the savings card route is the cheapest way to get brand-name tirzepatide. The path is different for the two indications.
Mounjaro savings card ($25/month)
- Requires Type 2 diabetes diagnosis
- Requires commercial insurance that covers Mounjaro for T2D
- Annual savings cap: $1,950
- Apply at Mounjaro.com, present at pharmacy
Zepbound savings card ($25/month)
- Requires obesity diagnosis (BMI 30+, or 27+ with comorbidity)
- Requires commercial insurance that covers Zepbound for weight management
- Annual savings cap: $1,950
- Apply at Zepbound.com, present at pharmacy
If your insurance plan has a GLP-1 weight-loss exclusion, the savings card alone won't bridge the gap and you'll fall back to the LillyDirect vial price or compounded.
4. Compounded Tirzepatide Oral and Troche: $279 to $399
For people who genuinely won't inject, several telehealth platforms now offer compounded tirzepatide as an oral tablet, sublingual troche, or liquid drop. Pricing tracks the injectable cost, sometimes slightly higher because the formulation is more specialized.
- MEDVi: compounded tirzepatide tablet $279 first month, $399 ongoing
- OnlineSemaglutide.org: tirzepatide drop $399 per month
- Shed: sublingual tirzepatide $349 to $499
The bioavailability of oral tirzepatide is meaningfully lower than injection (the molecule is a peptide and is partly degraded in the gut). For comparable weight-loss results, the dose has to be higher, which means the cost-per-effective-milligram is usually worse than the injectable form. The use case is needle aversion, not cost savings.
Why Tirzepatide Is the Most Effective GLP-1, Ranked Against Cost
Tirzepatide consistently outperforms semaglutide in head-to-head data. The SURMOUNT-1 trial showed 20.9% average body-weight reduction at the 15 mg dose over 72 weeks. Semaglutide (STEP-1) showed 14.9% over a similar period. That difference is large enough that even at a higher monthly cost, tirzepatide can be the better cost-per-pound-lost option.
| Drug | Avg. weight loss (trial) | Cheapest legal monthly cost | Cost per % body weight lost (rough) |
|---|---|---|---|
| Tirzepatide (compounded) | 20.9% | $125 to $349 | ~$430 to $1,200 per percentage point |
| Semaglutide (compounded) | 14.9% | $99 to $249 | ~$480 to $1,200 per percentage point |
| Liraglutide (compounded) | ~8% | $99 to $149 | ~$745 to $1,120 per percentage point |
For a deeper head-to-head comparison see our guide on weight loss peptides compared and the GLP-1 side effects breakdown.
State-by-State Pricing Variation at Local Clinics
Telehealth prices are roughly the same nationwide. In-person clinic prices vary wildly by state. Local clinic monthly costs for tirzepatide we've tracked:
- Texas, Florida, Arizona, Georgia, Tennessee: $400 to $500 per month
- California, New York, Massachusetts, Washington: $550 to $725 per month
- Mid-South and Midwest states: $425 to $550 per month
If telehealth works for you, ignore this. If you need an in-person clinic for any reason, expect to pay 2 to 4 times the cheapest telehealth price.
Hidden Costs That Inflate the Headline Price
The "$125 a month" headline almost never lands at $125. Here's what to actually budget for:
Add-on costs to factor in
- Membership fees: $20 to $50 per month on top of medication (Mochi, Hims, Ro, Noom)
- Lab work: $50 to $200 every 3 to 6 months (some platforms include)
- Shipping: $15 to $30 per refill if not free
- Dose-tier jumps: Most platforms raise prices 20% to 50% at 7.5 mg+
- Initial consultation: $19 to $129 one-time
- Auto-renewal lock-in: Lowest prices typically require 6 or 12 month prepay
- LillyDirect 45-day refill rule: miss the window and pricing resets
Compounded vs Brand: How to Decide
Choose compounded tirzepatide if
- You don't have insurance, or your insurance excludes GLP-1 weight-loss coverage.
- You want to start within a week.
- You've reviewed the contraindications and have no thyroid cancer history, no severe pancreatitis history, and aren't pregnant or planning pregnancy.
- You're comfortable that the finished formulation is not FDA-approved.
Choose LillyDirect Zepbound vials if
- You want FDA-approved tirzepatide at the lowest possible cash price.
- You're comfortable drawing your own dose with a syringe.
- You can commit to refilling within the 45-day window every cycle.
Choose savings card + brand pen if
- You have commercial insurance with GLP-1 coverage and a qualifying diagnosis.
- You'd rather pay $25 a month than navigate compounding or vial logistics.
- You want the auto-injector pen form factor.
Red Flags When Buying Cheap Tirzepatide
The cheap end of the tirzepatide market includes both legitimate compounding pharmacies and outright scams. Cheap is fine. Cheap with no medical oversight is not.
Walk away if a provider
- Doesn't require any medical intake or consultation.
- Won't name the compounding pharmacy supplying the medication.
- Sells "research-only" tirzepatide vials for human use (this is the gray-market peptide world, not compounded medicine).
- Won't provide a Certificate of Analysis on request.
- Asks for crypto, Zelle, or wire transfer.
- Has no licensed prescriber listed by name and state.
- Quotes a price under $90 per month for tirzepatide (not realistic from a legitimate 503A pharmacy at current API costs).
What's Coming Mid-2026: TrumpRx and Medicare Bridge
Two pricing changes could move the floor again this year:
TrumpRx.gov launches mid-2026 as a federal portal consolidating manufacturer cash-pay programs. Initial reporting suggests Zepbound will be available through it at roughly $350 per month, slightly above LillyDirect's vial pricing but with the pen-injector form factor.
The Medicare GLP-1 Bridge Program begins July 2026 and is expected to bring qualifying Medicare Part D beneficiaries to a $50 monthly copay for Mounjaro for diabetes indications. Coverage for obesity-only indications (Zepbound) remains excluded from Medicare law and is not part of the bridge.
Frequently Asked Questions
The Bottom Line
If you have commercial insurance and a qualifying diagnosis, the $25 savings card route wins. If you don't, compounded tirzepatide at $125 to $349 a month is the cheapest legal floor and the LillyDirect Zepbound vial at $299 is the cheapest FDA-approved cash option. Brand-name pen retail at $1,000+ is the worst value in the market in 2026 and almost nobody actually pays it.
Related: Tirzepatide Cost: Prices, Insurance & Cheapest Options · Tirzepatide Cost Without Insurance · Cheapest GLP-1 in 2026 · Compounded Tirzepatide Guide · GLP-1 Side Effects Compared